Moreover, serum level of PGLYRP2 was significantly correlated to SLEDAI, C3 and C4 in SLE patients, although it was not correlated to ANA and anti-dsDNA antibodies. This evidence concerns the gene PGLYRP2 and systemic lupus erythematosus.